Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2016
Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomasXuejun Tian, Ashley Pelton, Ali Shahsafaei, et al.
The Journal of Reproductive Medicine|June 18, 2002
Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classificationDavid R Genest, David M Dorfman, Diego H Castrillon
Human Pathology|February 16, 2005
The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disordersScott J Rodig, Aliakbar Shahsafaei, Betty Li, et al.
Human Pathology|May 29, 2017
T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiationDavid M Dorfman, Elizabeth A Morgan, Ashley Pelton, et al.
American Journal of Clinical Pathology|October 22, 2015
FLOCK cluster analysis of mast cell event clustering by high-sensitivity flow cytometry predicts systemic mastocytosisDavid M Dorfman, Charlotte D LaPlante, Olga Pozdnyakova, et al.
Leukemia & Lymphoma|January 9, 2014
Antigen expression patterns of MYC-rearranged versus non-MYC-rearranged B-cell lymphomas by flow cytometryDiana L Mandelker, David M Dorfman, Betty Li, et al.
Human Pathology|January 7, 2003
CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomasScott J Rodig, Dan Jones, Aliakbar Shahsafaei, et al.
The American Journal of Surgical Pathology|July 5, 2006
Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphomaDavid M Dorfman, Julia A Brown, Aliakbar Shahsafaei, et al.
Human Pathology|July 27, 2010
The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasmsDavid M Dorfman, Jason L Hornick, Aliakbar Shahsafaei, et al.
American Journal of Clinical Pathology|October 16, 2008
Comparison of Russell viper venom-based and activated partial thromboplastin time-based screening assays for resistance to activated protein CAdrianna Z Herskovits, Susan J Lemire, Janina Longtine, et al.
Pageof 12